No Detail Found!

Measuring The Level of MIR-148A in Iraqi Women Diagnosed with Breast Cancer

Author(s)
MUNA SHUKRI MAHMOOD AL-MASHHADANI College of Education for Pure Science (Ibn Al-Haitham) / University of Baghdad, Iraq
WAFAA SABRI MAHOOD College of Education for Pure Science (Ibn Al-Haitham) / University of Baghdad, Iraq
HAZIMA MOSSA AL-ABASSI College of Education for Pure Science (Ibn Al-Haitham) / University of Baghdad, Iraq
Abstract
Background: Breast cancer is the most common type of cancer in Iraq, and the incidence of it has increased among Iraqi women in the past two decades, as it represents one of the most important threats to women's health. Aim: this study aimed to investigate the miR-148a gene expression as a biomarker in different age groups of Iraqi women with breast cancer, as well as its association with patient characteristics such as body mass index, disease stage, and tumor location. Method: Fifty women diagnosed with breast cancer were enrolled in this study in addition to 25 healthy individuals as a control group. The fold expression (FE) of miRNA-148a was detected by quantitative polymerase chain reaction (qPCR) techniques. Results: The results showed the highest significant difference in the gene expression of miR-148a in breast cancer patients in the age group (50) compared to the control group, and the difference was significant in the age group (<40) compared to the control group, highly significant differences was found in the age group (40-49) compared with the control group. The results also showed no significant differences in the fold level of gene expression for miR-148a in the grades (I, II, and III) of breast cancer patients, and that the highest level was recorded in the second grade, and the highest level was recorded in the grade.
Publication Details
Page(s) 560-564
Published Journal: Pakistan Journal of Medical and Health Sciences, Volume: 16, Issue: 06, Year: 2022

Request the full text from PASTIC

Keywords
Breast cancer, BMI, miR-148a
References
Abdulkareem and H. M. Al-Abassi Z. J. .2019 .Serum Level of ST2 with Gene's Distal Promoter Polymorphism in Iraqi Females with Breast Cancer,”. J. Pharm. Sci. Res, 11(6) : 2333-2340.
Salman . .-bp Insertion/Deletion (In/Del) Polymorphism in Breast Cancer Iraqi Arabian Women. ” Indian J. Forensic Med, : .
Toxicol. .2021 .. , 15(3) : 1109.
Li X. . .“miR‑ 150 inhibits proliferation and tumorigenicity via retarding G1/S phase transition in nasopharyngeal carcinoma,” Int. , : .
Oncol. .2017 .. , 50(4) : 1097-1108.
.2007 .. , (17) : 5944-5953.
Imani R.,Seyedmajidi M.,Ghasemi N.,Moslemi D.,Shafaee S.,Bijani A. .2018 .HLA-G expression is associated with an unfavorable prognosis of oral squamous cell carcinoma,” Asian Pacific J. Cancer Prev. APJCP, 19(9) : 2527.
M. J. Hasen W. S.,Mahood W. S.,Pharm J. . .Evaluation of the microRNA-328 gene expression in some Iraqi breast cancer women,”. , : .
Res. .2019 .. , 11(6) : 2347-2352.
Mahood W. S.,Hasan M. J.,Mohammed M. J.,AL-Haitham J .2021 .Gene Expression of MicroRNA-370 in Some Iraqi Women with Breast Cancer,” Ibn. Pure Appl. Sci., : 57-67.
Yang J. .2015 .miR-21 as novel biomarkers in non-small cell lung cancer screening,” Tumor Biol. “Serum miR-152, 36(4) : 3035-3042.
Xu Q. .2015 .. “Regulatory circuit of PKM2/NF-κB/miR-148a/152- modulated tumor angiogenesis and cancer progression,” Oncogene, 34(43) : 5482-5493.
Sakamoto N. .2014 .“Micro RNA‐148a is downregulated in gastric cancer, targets MMP 7, and indicates tumor invasiveness and poor prognosis,” Cancer Sci. , 105(2) : 236-243.
Wang X. . .Evidence that miR-133a causes recurrent spontaneous abortion by reducing HLA-G expression. , : .
Biomed .2012 .. , 25(4) : 415-424.
Xiang Y. . .-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine,” Oncogene. “MiR-152 and miR-185, 33 : .
.2014 .. , : 378-386.
K. J. Livak T. D.,Schmittgen T. D. .2001 .Analysis of relative gene expression data using real-time quantitative PCR and the 2− ΔΔCT method,” methods. , 25(4) : 402-408.
Baltruskeviciene E. .2017 .-3p in colorectal cancer is associated with tumor budding. ” BMC Cancer, 17(1) : 1-10.
Chen Q.,Zhang X. .2017 .influences tumor apoptosis in esophageal squamous cell carcinoma. ” Exp. Ther. Med, 14(5) : 4448-4452.
Zhang H. .2011 .“MiR-148a promotes apoptosis by targeting Bcl-2 in colorectal cancer,” Cell Death Differ. , 18(11) : 1702-1710.
Fouda .2021 .miRNA-148a and miRNA-30c expressions as potential biomarkers in breast cancer patients. ” Biochem. Biophys. Reports, 27 : 101060.
Huang Z. .2020 .“MicroRNA-148a-3p inhibits progression of hepatocelluar carcimoma by repressing SMAD2 expression in an Ago2 dependent manner. ” J. Exp. Clin. Cancer Res., 39(1) : 1-12.
Zhang Y.,Jin X.,Wang J. . .miR‑ 148a modulates the viability, migration and invasion of oral squamous cell carcinoma cells by regulating HLA‑. ” Mol. Med, 20(1) : .
Yu B. .2016 .“MiR-148a functions as a tumor suppressor by targeting CCK-BR via inactivating STAT3 and Akt in human gastric cancer. PLoS One, 11(8) : e0158961.
Xu Q. .2013 .“A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGFIR and IRS1. Mol. Cell Biol, 5(1) : 3-13.
M. Javadian ,Cell J. . .The role of microRNAs regulating the expression of matrix metalloproteinases (MMPs) in breast cancer development, progression, and metastasis,”. , 234(5) : .
Xue J.,Chen Z.,Gu X.,Zhang Y. .2016 .MicroRNA-148a inhibits migration of breast cancer cells by targeting. , 37(2) : 1581-1590.
Zamanillo R.,Sánchez J.,Serra F.,Palou A. .2019 .Breast milk supply of microRNA associated with leptin and adiponectin is affected by maternal overweight/obesity and influences infancy BMI,” Nutrients. , 11(11) : 2589.
Li Y.,Deng X.,Zeng X.,Peng X. .2016 .The role of Mir-. in cancer,” J. cancer, 7(10) : 1233.
Xu X. .2016 .“MiR-148a functions to suppress metastasis and serves as a prognostic indicator in triple-negative breast cancer. ” Oncotarget, 7(15) : 20381.
Pan L.,Huang S.,He R.,Rong M.,Dang Y.,Med Eur. J. .2014 .Decreased expression and clinical significance of miR-148a in hepatocellular carcinoma tissues,”. , 19(1) : 1-6.
Jiang Q. . .“MicroRNA-148a inhibits breast cancer migration and invasion by directly targeting WNT-1,”. Oncol. Rep, 35(3) : .
Ma L.,Xu Z.,Xu C.,Jiang X. . .MicroRNA-148a represents an 30 31 independent prognostic marker in bladder cancer,” Tumor Biol. , : .
.2016 .. , (6) : 7915-7920.
Chen Y. . .Decreased miRNA-148a is associated with lymph node metastasis and poor clinical outcomes and functions as a suppressor of tumor metastasis in non-small cell lung cancer. , : .
Rep. .2013 .. , 30(4) : 1832-1840.
Chen H.,Zhou M.,Tian W.,Meng K.,He H. .2016 .Effect of age on breast cancer patient prognoses: a population-based study using the SEER 18 database. PLoS One, 11(10) : e0165409.
Gong L.,Wang C.,Gao Y.,Wang J. . .Decreased expression of microRNA-148a predicts poor prognosis in ovarian cancer and associates with tumor growth and metastasis. , : .
Pharmacother. .2016 .. , 83 : 58-63.
0

Citations

0

Downloads

63

Views